International survey presented at TOXINS 2019 reveals hidden burden of spasticity 1 PARIS--(BUSINESS WIRE)--Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) today presents at TOXINS, results from an ...
A advancement in the diagnosis of upper limb (UL) spasticity is on the horizon, moving beyond traditional reliance on clinicians' tactile assessments. Researchers affiliated with UNIST have developed ...
Interim data from the ongoing EPITOME trial1 showed that 45.7% of stroke survivors with paresis developed post-stroke spasticity within 1 year<1% of stroke survivors receive BoNT-A treatment for ...
The spasticity market is expected to grow due to factors like an increase in the patient pool and the expected entry of emerging therapies. Spasticity, a prevalent secondary issue in various ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results